Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095075
Filing Date
2024-08-12
Accepted
2024-08-12 08:13:47
Documents
55
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q coya-20240630.htm   iXBRL 10-Q 1313914
2 EX-31.1 coya-ex31_1.htm EX-31.1 19359
3 EX-31.2 coya-ex31_2.htm EX-31.2 19173
4 EX-32.1 coya-ex32_1.htm EX-32.1 15021
  Complete submission text file 0000950170-24-095075.txt   5630195

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT coya-20240630.xsd EX-101.SCH 935682
58 EXTRACTED XBRL INSTANCE DOCUMENT coya-20240630_htm.xml XML 804476
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41583 | Film No.: 241194813
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)